Why People Regain Weight After Stopping GLP-1s — And How to Prevent It

I had a patient sit across from me last week, visibly upset. She’d lost 40 pounds on semaglutide over eight months. Then she stopped the medication — and within five months, she’d regained almost all of it.

“I feel like I failed,” she told me.

She didn’t fail. The system she was in failed her.

This is one of the most important conversations happening in obesity medicine right now, and I want to be direct with you about what the data actually shows — and what you can do about it.

The Research Is Clear: Weight Regain Is Real

Data published in The BMJ in January 2026 confirmed what many of us in obesity medicine have been warning about: patients who stop GLP-1 medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) regain weight approximately four times faster than people who lose weight through lifestyle changes alone. In their systematic review of 37 studies and over 9,300 participants, the Oxford research team found that patients regained an average of 9.9 kg in the first year after stopping, at a rate of 0.8 kg per month — with projected return to baseline weight within 18 months.

Let that sink in for a moment.

A separate CNN report highlighted that roughly half of patients on GLP-1 medications discontinue them within the first year — whether due to cost, side effects, insurance changes, or the belief that the weight loss is “done.” A large cohort study of over 125,000 patients found that 46.5% of patients with type 2 diabetes and 64.8% without discontinued within one year. And when they stop, the weight comes back aggressively.

This doesn’t mean GLP-1 medications don’t work. They absolutely do. The SURMOUNT-5 trial, published in the New England Journal of Medicine, showed tirzepatide producing 20.2% body weight loss and semaglutide 13.7% over 72 weeks in a head-to-head comparison of 751 patients. These are remarkable results. But a medication alone, without a foundation underneath it, is like building a house on sand.

Why the Rebound Happens

Here’s what I explain to every patient who walks through my door: GLP-1 medications work primarily by reducing appetite and slowing gastric emptying. They change the signals your brain receives about hunger and fullness. That’s powerful — but it doesn’t change your metabolic engine.

When you lose weight rapidly on a GLP-1 without strategic intervention, you don’t just lose fat. You lose muscle. A review published in Diabetes, Obesity and Metabolism found that lean body mass can account for 25% to 39% of total weight lost with GLP-1 therapies over 36–72 weeks. A separate analysis in The Lancet Diabetes & Endocrinology confirmed that without resistance training, muscle loss during medically induced weight loss is clinically significant. And muscle is your metabolic furnace — it’s what burns calories at rest, regulates blood sugar, protects your joints, and keeps you functionally strong as you age.

So when you stop the medication, you’ve lost muscle, your metabolic rate has dropped, and the appetite suppression disappears. Your body is now primed to regain fat — and that’s exactly what happens.

The Approach That Changes the Equation

This is precisely why I built TouchCare Method around a physician-led, multi-pillar approach. The medication is one tool — an important one — but it’s never the whole plan. Here’s what a comprehensive protocol actually looks like:

The TouchCare Method Protocol

Strategic Strength Training. This is non-negotiable. A 2025 systematic review and meta-analysis found that resistance training during caloric restriction is the most effective intervention for maintaining lean body mass while reducing body fat. If you are on a GLP-1 medication and you are not doing resistance training at least two to three times per week, you are losing muscle you cannot afford to lose. I prescribe strength training the same way I prescribe medication — with specific frequency, intensity, and progression.

Protein Optimization. Most patients on GLP-1 medications aren’t eating enough protein, partly because their appetite is so suppressed. Expert consensus suggests patients on GLP-1 receptor agonists need 1.0–1.5 grams of protein per kilogram of ideal body weight daily, with some recommendations going as high as 1.2–1.6 g/kg for active muscle preservation. I work with each patient to ensure they’re hitting these targets.

Personalized Supplementation. Rapid weight loss can create nutrient gaps. I assess each patient’s labs and build a supplementation protocol that addresses deficiencies in vitamin D, magnesium, B vitamins, omega-3s, and other nutrients critical to metabolic function. This isn’t about selling supplements — it’s about making sure your body has what it needs to function optimally during a major metabolic shift.

Metabolic Monitoring. I track metabolic markers regularly — not just body weight, but body composition, insulin sensitivity, inflammatory markers, and hormone levels. This data tells me when we need to adjust the plan, when someone is losing too much muscle, or when metabolic adaptation is setting in.

What to Do If You’re Thinking About Stopping

If you’re considering discontinuing your GLP-1 medication, please don’t do it cold turkey without a plan. Here’s my guidance:

First, have an honest conversation with your physician about why you want to stop and what a safe taper looks like. Some patients can successfully reduce their dose gradually while maintaining their results.

Second, make sure you’ve built the metabolic foundation first. Are you strength training consistently? Is your protein intake where it needs to be? Have you addressed sleep, stress, and any underlying metabolic issues? These are the pillars that hold your results when the medication is reduced or removed.

Third, understand that for many patients, obesity is a chronic condition that may require ongoing treatment — just like blood pressure or diabetes medication. There’s no shame in staying on a medication that’s working for you. The goal isn’t to stop treatment. The goal is to be healthy.

The Bottom Line

GLP-1 medications are genuinely transformative. They’ve changed the landscape of obesity medicine, and I prescribe them to patients who are good candidates. But I refuse to let my patients become a statistic in the weight regain data.

The difference between a prescription and a protocol is everything. A prescription gives you a medication. A protocol gives you a foundation — one built on evidence, personalized to your body, and designed to last whether you stay on the medication or eventually step away from it.

If you’re on a GLP-1 medication right now, ask yourself: What’s my plan beyond the prescription? If you don’t have a clear answer, that’s exactly the conversation I want to have with you.